VRPX
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
VRPX
Delisted
VRPX was delisted on the 3rd of April, 2025.
14 hedge funds and large institutions have $3.13M invested in Virpax Pharmaceuticals, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
86% less capital invested
Capital invested by funds: $21.6M → $3.13M (-$18.5M)
Holders
14
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$127K | |
| 2 | +$91.1K | |
| 3 | +$78.4K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$19K |
| 5 |
QPW
Quantum Private Wealth
Tampa,
Florida
|
+$16K |
Top Sellers
| 1 | -$1.67M | |
| 2 | -$101K | |
| 3 | -$27K | |
| 4 |
JPMorgan Chase & Co
New York
|
-$6K |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$836 |